Elham Malekzadeh

Senior Scientist Takeda Pharmaceutical

Seminars

Wednesday 29th April 2026
Validating Organ-on-Chip Models Across Platforms to Enhance Safety Predictions & Translational Accuracy
4:30 pm
  • Establishing project-specific validation criteria for organ-on-chip systems to assess translatability against animal studies and clinical outcomes
  • Implementing multi-organ approaches including blood, liver, and skin-on-chip models to address diverse safety and efficacy questions
  • Standardizing assay protocols across cell therapy and small molecule platforms to ensure reproducible safety hazard predictions
Wednesday 29th April 2026
Enhancing Predictive Toxicity Assessment Through 3D In Vitro Systems to Accelerate Safe Drug Development
Malek Zadeh Elham, Senior Scientist, Takeda Pharmaceutical